Case of vemurafenib-induced Sweet's syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Case of vemurafenib-induced Sweet's syndrome

Published:2014-03-12 Issue:9 Volume:41 Page:817-820
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Yorio Jeffrey T.¹,Mays Steven R.²,Ciurea Ana M.²,Cohen Philip R.²,Wang Wei-Lien³,Hwu Wen-Jen¹,Gonzalez Nydia¹,Richard Jessica L.¹,Kim Kevin B.¹

Affiliation:

1. Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas USA

2. Department of Dermatology; The University of Texas MD Anderson Cancer Center; Houston Texas USA

3. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas USA

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.12430/fullpdf

Reference15 articles.

1. Distinct sets of genetic alterations in melanoma;Curtin;N Engl J Med,2005

2. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

3. Vemurafenib-induced neutrophilic panniculitis;Monfort;Melanoma Res,2012

4. Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management;Zimmer;Arch Dermatol,2012

5. An acute febrile neutrophilic dermatosis;Sweet;Br J Dermatol,1964

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sweet syndrome in a patient receiving encorafenib and binimetinib therapy for malignant melanoma;JAAD Case Reports;2024-03

2. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies;American Journal of Clinical Dermatology;2023-07-03

3. Drug-Induced Subcutaneous Sweet Syndrome;Mayo Clinic Proceedings;2023-04

4. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-03

5. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview;Cancers;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3